163 related articles for article (PubMed ID: 33569740)
1. Overexpression of SERPINA3 promotes tumor invasion and migration, epithelial-mesenchymal-transition in triple-negative breast cancer cells.
Zhang Y; Tian J; Qu C; Peng Y; Lei J; Li K; Zong B; Sun L; Liu S
Breast Cancer; 2021 Jul; 28(4):859-873. PubMed ID: 33569740
[TBL] [Abstract][Full Text] [Related]
2. PKMYT1 Promotes Epithelial-Mesenchymal Transition Process in Triple-Negative Breast Cancer by Activating Notch Signaling.
Li B; Huang L; Ruan J
Rev Invest Clin; 2024; 76(1):45-59. PubMed ID: 38442372
[TBL] [Abstract][Full Text] [Related]
3. Tabersonine enhances cisplatin sensitivity by modulating Aurora kinase A and suppressing epithelial-mesenchymal transition in triple-negative breast cancer.
Chen X; Yan Y; Liu Y; Yi Q; Xu Z
Pharm Biol; 2024 Dec; 62(1):394-403. PubMed ID: 38739003
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of FGF9 and NOVA1 in cancer-associated fibroblasts promotes cell proliferation, invasion and migration of triple negative breast cancer.
Zhang B; Liu Y; Yu J; Lin X
Drug Dev Res; 2024 May; 85(3):e22185. PubMed ID: 38657094
[TBL] [Abstract][Full Text] [Related]
5. The deubiquitinase BRCC3 increases the stability of ZEB1 and promotes the proliferation and metastasis of triple-negative breast cancer cells.
Huang Q; Zheng S; Gu H; Yang Z; Lu Y; Yu X; Guo G
Acta Biochim Biophys Sin (Shanghai); 2024 Apr; 56(4):564-575. PubMed ID: 38449391
[TBL] [Abstract][Full Text] [Related]
6. Silencing of Prrx1b suppresses cellular proliferation, migration, invasion and epithelial-mesenchymal transition in triple-negative breast cancer.
Lv ZD; Yang ZC; Liu XP; Jin LY; Dong Q; Qu HL; Li FN; Kong B; Sun J; Zhao JJ; Wang HB
J Cell Mol Med; 2016 Sep; 20(9):1640-50. PubMed ID: 27027510
[TBL] [Abstract][Full Text] [Related]
7. Desmoglein 2 and desmocollin 2 depletions promote malignancy through distinct mechanisms in triple-negative and luminal breast cancer.
Han JY; Che N; Mo J; Zhang DF; Liang XH; Dong XY; Zhao XL; Sun BC
BMC Cancer; 2024 Apr; 24(1):532. PubMed ID: 38671389
[TBL] [Abstract][Full Text] [Related]
8. Reciprocal regulation of forkhead box C1 and L1 cell adhesion molecule contributes to triple-negative breast cancer progression.
Zhang F; Xu Y; Lin J; Pan H; Giuliano AE; Cui X; Cui Y
Breast Cancer Res Treat; 2024 Apr; 204(3):465-474. PubMed ID: 38183514
[TBL] [Abstract][Full Text] [Related]
9. LncRNA SOX9-AS1 triggers a transcriptional program involved in lipid metabolic reprogramming, cell migration and invasion in triple-negative breast cancer.
Cisneros-Villanueva M; Fonseca-Montaño MA; Ríos-Romero M; López-Camarillo C; Jiménez-Morales S; Langley E; Rosette-Rueda AS; Cedro-Tanda A; Hernández-Sotelo D; Hidalgo-Miranda A
Sci Rep; 2024 Jan; 14(1):1483. PubMed ID: 38233470
[TBL] [Abstract][Full Text] [Related]
10. Nuclear isoform of RAPH1 interacts with FOXQ1 to promote aggressiveness and radioresistance in breast cancer.
Liu Q; Cao Y; Wei X; Dong H; Cui M; Guan S; Liu B; Wang X; Xing P
Cell Death Dis; 2023 Dec; 14(12):803. PubMed ID: 38062011
[TBL] [Abstract][Full Text] [Related]
11. LIPH promotes metastasis by enriching stem-like cells in triple-negative breast cancer.
Zhang Y; Zhu X; Qiao X; Gu X; Xue J; Han Y; Sun L; Cui M; Liu C
J Cell Mol Med; 2020 Aug; 24(16):9125-9134. PubMed ID: 32618099
[TBL] [Abstract][Full Text] [Related]
12. Leptin Signaling Mediates Obesity-Associated CSC Enrichment and EMT in Preclinical TNBC Models.
Bowers LW; Rossi EL; McDonell SB; Doerstling SS; Khatib SA; Lineberger CG; Albright JE; Tang X; deGraffenried LA; Hursting SD
Mol Cancer Res; 2018 May; 16(5):869-879. PubMed ID: 29453319
[TBL] [Abstract][Full Text] [Related]
13. Ezetimibe inhibits the migration and invasion of triple-negative breast cancer cells by targeting TGFβ2 and EMT.
Kong L; He Q; Ma D; Shi W; Xin Q; Jiang C; Wu J
FEBS Open Bio; 2024 May; 14(5):831-842. PubMed ID: 38531630
[TBL] [Abstract][Full Text] [Related]
14. Imbalance between Actin Isoforms Contributes to Tumour Progression in Taxol-Resistant Triple-Negative Breast Cancer Cells.
Dugina V; Vasileva M; Khromova N; Vinokurova S; Shagieva G; Mikheeva E; Galembikova A; Dunaev P; Kudlay D; Boichuk S; Kopnin P
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674115
[TBL] [Abstract][Full Text] [Related]
15. Exploration of MELK as a downstream of Del-1 and druggable targets in triple-negative breast cancer.
Lee IH; Lee SJ; Kang B; Lee J; Jung JH; Park HY; Park JY; Park NJ; Kim EA; Kang J; Chae YS
Breast Cancer Res Treat; 2024 May; 205(1):181-191. PubMed ID: 38279017
[TBL] [Abstract][Full Text] [Related]
16. The Nek2 centrosome-mitotic kinase contributes to the mesenchymal state, cell invasion, and migration of triple-negative breast cancer cells.
Rivera-Rivera Y; Marina M; Jusino S; Lee M; Velázquez JV; Chardón-Colón C; Vargas G; Padmanabhan J; Chellappan SP; Saavedra HI
Sci Rep; 2021 Apr; 11(1):9016. PubMed ID: 33907253
[TBL] [Abstract][Full Text] [Related]
17. Alpha 1-antichymotrypsin contributes to stem cell characteristics and enhances tumorigenicity of glioblastoma.
Lara-Velazquez M; Zarco N; Carrano A; Phillipps J; Norton ES; Schiapparelli P; Al-Kharboosh R; Rincon-Torroella J; Jeanneret S; Corona T; Segovia J; Jentoft ME; Chaichana KL; Asmann YW; Quiñones-Hinojosa A; Guerrero-Cazares H
Neuro Oncol; 2021 Apr; 23(4):599-610. PubMed ID: 33249487
[TBL] [Abstract][Full Text] [Related]
18. miRNA-200c-3p deficiency promotes epithelial-mesenchymal transition in triple-negative breast cancer by activating CRKL expression.
Nie F; Zhang Q; Ma W; Yan J
Discov Oncol; 2024 May; 15(1):146. PubMed ID: 38717531
[TBL] [Abstract][Full Text] [Related]
19. TROP2 is highly expressed in triple-negative breast cancer CTCs and is a potential marker for epithelial mesenchymal CTCs.
Liao Q; Zhang R; Ou Z; Ye Y; Zeng Q; Wang Y; Wang A; Chen T; Chai C; Guo B
Mol Ther Oncol; 2024 Mar; 32(1):200762. PubMed ID: 38596285
[TBL] [Abstract][Full Text] [Related]
20. QSOX2 Upregulated in triple-negative breast cancer exacerbates patient prognosis by stabilizing integrin β1.
Kim AI; Oh JH; Cho JY
Heliyon; 2024 Mar; 10(6):e27148. PubMed ID: 38500982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
